Suppr超能文献

[4型淋巴细胞消减型霍奇金病。35例病例的解剖临床回顾]

[Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].

作者信息

Eghbali H, Pétorin C, de Mascarel I, Trojani M, Hoerni-Simon G, Soubeyran P, Hoerni B

机构信息

Fondation Bergonié, Bordeaux, France.

出版信息

Bull Cancer. 1994 Oct;81(10):866-70.

PMID:7734769
Abstract

The pathological material of 35 patients with Hodgkin's disease lymphocyte-depletion type (type 4) is reviewed with an immunohistochemistry study on paraffin-embedded sections. The new pathologic data are compared with clinical features. These 35 patients are 4.7% of 742 previously untreated patients managed in this institution from 1960 to 1991. The diagnosis of 31 of the 35 patients was rectified, 17 to non-Hodgkin's lymphoma (12 unclassifiable and five anaplastic Ki-1 positive) and 14 to another type of Hodgkin's disease (six nodular sclerosis and eight mixed cellularity). In four cases, the pathologic material was neither sufficient nor satisfactory to allow a clear-cut distinction between Hodgkin's disease and non-Hodgkin's lymphoma. The analysis of clinical data before and after pathological revision did not show any difference in clinical features, either between Hodgkin's disease "type 4" and other types (1, 2 or 3) or between cases with Hodgkin's disease and those with non-Hodgkin's lymphoma. There is, however, a significant male predominance for Hodgkin's disease versus non-Hodgkin's lymphoma (P = 0.029, exact Fisher test), and B symptoms in non-Hodgkin's lymphomas (P = 0.056), whereas B symptoms are commonly seen in advanced stages of Hodgkin's disease. It is emphasized that all Hodgkin's disease of lymphocyte-depletion type should be reviewed and discussed before any treatment, and this diagnosis actually means non-Hodgkin's lymphoma or other types of Hodgkin's disease.

摘要

对35例霍奇金病淋巴细胞消减型(4型)患者的病理材料进行回顾,并对石蜡包埋切片进行免疫组织化学研究。将新的病理数据与临床特征进行比较。这35例患者占1960年至1991年在本机构接受治疗的742例未经治疗患者的4.7%。35例患者中有31例的诊断得到纠正,其中17例纠正为非霍奇金淋巴瘤(12例无法分类,5例间变性Ki-1阳性),14例纠正为其他类型的霍奇金病(6例结节硬化型和8例混合细胞型)。在4例中,病理材料既不充分也不令人满意,无法明确区分霍奇金病和非霍奇金淋巴瘤。病理修正前后临床数据的分析显示,无论是霍奇金病“4型”与其他类型(1、2或3型)之间,还是霍奇金病患者与非霍奇金淋巴瘤患者之间,临床特征均无差异。然而,霍奇金病相对于非霍奇金淋巴瘤存在显著的男性优势(P = 0.029,确切概率法Fisher检验),非霍奇金淋巴瘤中B症状更为常见(P = 0.056),而B症状在霍奇金病晚期较为常见。强调所有淋巴细胞消减型霍奇金病在进行任何治疗前都应进行回顾和讨论,实际上这种诊断意味着非霍奇金淋巴瘤或其他类型的霍奇金病。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验